AGN 1.28% 79.0¢ argenica therapeutics limited

Ann: Preclinical HIE Study - ARG007 Effective Stand-Alone Therapy, page-2

  1. 9,821 Posts.
    lightbulb Created with Sketch. 971
    Brilliant results and Stan Perron Charitable Foundation is paying for all test results up to a clinical trial on infants.

    Zero competition in the HIE space and results have been far superior to the current method of hypothermia.

    I wonder at what stage we can apply for the FDA Paediatric Review Voucher and if granted would we sell it for an estimate of $100 million or use it to fastrack ARG 007 FDA approval for HIE applications.
 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
(20min delay)
Last
79.0¢
Change
0.010(1.28%)
Mkt cap ! $100.4M
Open High Low Value Volume
78.0¢ 80.5¢ 78.0¢ $71.40K 90.43K

Buyers (Bids)

No. Vol. Price($)
1 15000 78.5¢
 

Sellers (Offers)

Price($) Vol. No.
80.5¢ 2444 1
View Market Depth
Last trade - 15.55pm 23/08/2024 (20 minute delay) ?
AGN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.